DURECT Inks Co-marketing And Collaboration Deal With Charles River For ALZET Product Line

Charles River Laboratories Slashes FY24 Outlook - Update

RTTNews | 455日前

Charles River Laboratories Reaffirms FY24 Outlook; Q1 Results Top Estimates

While reporting financial results for the first quarter on Thursday, Charles River Laboratories International, Inc. (CRL) reaffirmed its adjusted earnings, revenue growth and organic revenue growth guidance range for the full-year 2024.

RTTNews | 545日前

Charles River Laboratories Narrows FY23 Outlook Range; Q3 Results Top Estimates

While reporting financial results for the first quarter on Thursday, Charles River Laboratories International, Inc. (CRL) narrowed its earnings, adjusted earnings, revenue growth and organic revenue growth guidance range for the full-year 2023.

RTTNews | 728日前

Charles River Labs Boosts FY23 Outlook As Q2 Results Top Estimates

While reporting financial results for the first quarter on Thursday, Charles River Laboratories International, Inc. (CRL) raised its adjusted earnings, revenue growth and organic revenue growth guidance for the full-year 2023, to reflect the strong first-quarter financial performance and expectations for the remainder of the year that are largely consistent with its initial outlook.

RTTNews | 909日前

Charles River Labs Slashes FY22 Outlook; Q2 Adj. EPS Tops Estimates, Revenues Miss

While reporting financial results for the second quarter on Wednesday, Charles River Laboratories International, Inc. (CRL) slashed its earnings, adjusted earnings, revenue growth and organic revenue growth guidance for the full-year 2022, due primarily to headwinds associated with the CDMO business, foreign exchange, and interest expense due to the rising interest rate environment.

RTTNews | 1190日前

DURECT Appoints Timothy Papp As New CFO

Biopharmaceutical company DURECT Corp. (DRRX) announced Tuesday the appointment of Timothy Papp as its Chief Financial Officer. Papp brings over 25 years of corporate finance experience to DURECT, including 15 years in the Biopharma sector.

RTTNews | 1219日前

Singapore Shares May Find Traction On Thursday

The Singapore stock market has moved lower in two straight sessions, slumping more than 25 points or 0.6 percent along the way. The Straits Times Index now sits just beneath the 4,420-point plateau although it may find support on Thursday.

RTTNews | 1時32分前

Rebound Anticipated For Malaysia Stock Market

The Malaysia stock market on Wednesday snapped the two-day winning streak in which it had collected almost 15 points or 0.9 percent. The Kuala Lumpur Composite Index now sits just above the 1,620-point plateau although it figures to bounce higher again on Thursday.

RTTNews | 2時2分前

EURUSD	1.14968	GBPUSD	1.30529	AUDUSD	0.65032
USDJPY	153.961	USDCAD	1.41051	USDCHF	0.8095